Qiagen
NYSE:QGEN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
WA
Consensus Narrative from 16 Analysts
Launches Of QIAstat Rise And QIAcuity Diagnostic Will Broaden Future Applications In Oncology And Infectious Diseases
Key Takeaways Expansion of QIAstat platform and new FDA clearances aim to boost revenue with U.S. launch of QIAstat Rise for high-throughput applications. Enhancements in digital PCR and automated sample preparation systems target growth in oncology, infectious diseases, and liquid biopsy markets.
View narrativeUS$49.70
FV
19.9% undervalued intrinsic discount6.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
8 days ago author updated this narrative